Our team published the most comprehensive, chromosome scale annotated reference genome for Psilocybe cubensis, and since then we have sequenced more than 100 P. cubensis genomes. We used that information and experience to design the PsiloSEEK® assay so that labs and growers can confirm P. cubensis genetics with a simple qPCR assay.
PsiloSEEK® can be run on multiple qPCR instruments and easily automated on liquid handling automation solutions from Agilent Technologies, Hamilton Robotics, and MGI/BGI.
Our team has provided Cannabis-specific qPCR assays to the field since 2015, covering a variety of targets, including human pathogens, plant pathogens, plant sex, genetic trait screening, and more. Testing labs around the world trust Medicinal Genomics, and several assays have received AOAC approval.
The Medicinal Genomics team has made significant contributions to the field of psychedelic mushroom sequencing and analysis.
K McKernan, L Kane, Y Helbert, L Zhang, N Houde, S McLaughlin
F1000Research 10 (961), 961
K McKernan, L Kane, S Crawford, C Chin, A Trippe, S McLaughlin,
F1000Research 2021, 10:281
Click to explore Psilocydia.net
Results are mapped to the most complete and comprehensive P. cubensis reference genome assembled by Medicinal Genomics, and reports are delivered on Psilocydia.net with the following information:
During this webinar we will explore:
Interested in learning more about onboarding mushroom speciation? Fill out the form below and a sales representative will be in touch with more details.
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.
